Cargando…

Role of multimodality therapy in cIIIA-N2 non–small cell lung cancer: perspective(§)

A number of promising new approaches for both local and systemic control of locally advanced non–small cell lung cancer have been examined in clinical trials, aimed at improving the patient survival. Development of better systemic therapies by adopting newer agents (such as epidermal growth factor r...

Descripción completa

Detalles Bibliográficos
Autor principal: Horinouchi, Hidehito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144660/
https://www.ncbi.nlm.nih.gov/pubmed/27702837
http://dx.doi.org/10.1093/jjco/hyw131